百合股份: 威海百合生物技术股份有限公司董事减持股份结果公告

Summary of Key Points Core Viewpoint - The announcement details the completion of a share reduction plan by the company's director, Wang Wentong, who has reduced his holdings in the company. Group 1: Shareholding Information - Before the reduction plan, director Wang Wentong held 1,697,518 shares, accounting for 2.65% of the company's total share capital [1] - The shares held by Wang Wentong were all acquired prior to the company's initial public offering [1] Group 2: Reduction Plan Implementation - The reduction plan was first disclosed on May 22, 2025, with the reduction period set from June 13 to July 16, 2025 [2] - Wang Wentong has reduced his holdings by 424,000 shares, which is 0.6625% of the company's total share capital, through centralized bidding [2] - The total amount from the reduction was 19,145,390 yuan, with the share price ranging from 44.42 to 45.55 yuan per share [2] - After the reduction, Wang Wentong holds 1,273,518 shares, representing 1.99% of the company's total share capital [2]